Reimbursement
Resources

CCTA Reimbursement Has Been Increased.

 

CMS has approved an elevated Ambulatory Payment Classification (APC) for Coronary CTA (CCTA), doubling reimbursement in the hospital setting and increasing payments in the Physician Fee Schedule (PFS) setting.
CCTA is the recommended first-line pathway for diagnosing patients with suspected coronary artery disease (CAD). This increase to reimbursement reflects CMS’s understanding of the superior efficiency and effectiveness of the patient pathway. The change in reimbursement more appropriately reflects the value CCTA provides in cardiac care and will help make this technology more widely available.

View Reimbursement by State

Hospital Outpatient: OPPS Final Rule

Product CY 2024 Final Rule CY 2025 Final Rule % Change
CCTA $175 APC 5571 $357 APC 5572 +104%
FFRCT APC 5724 $997 $1,017 +2%
Plaque APC 1151 $950 $950

Physician Office: PFS Final Rule

Product CY 2024 Final Rule CY 2025 Final Rule % Change
CCTA $285 $318 +12%
FFRCT APC 5724 $888 $839 -5.8%
Plaque Set by MACs Set by MACs
Note: Global Rates for PFS Setting.

Ensuring Patient Access — An Established Reimbursement Pathway

The Heartflow FFRCT Analysis is the first non-invasive diagnostic tool that aids clinicians in determining, vessel-by-vessel and lesion-by-lesion, both the extent of an artery’s narrowing and the impact that each narrowing has on blood flow to the heart.

By non-invasively identifying which patients, vessels, and lesions do and do not need intervention, clinicians can optimize appropriate use of invasive testing, reduce healthcare system costs and improve patient quality of life.

FFRCT Receives
Category I CPT® Code

The American Medical Association (AMA) released new coding guidance for FFRCT Category I code (CPT® 75580). FFRCT must augment physician decision making and requires FFRCT values, interactivity, lesion-by-lesion interrogation, and targeting.

Be confident that Heartflow’s FFRCT Analysis allows you to enable patient care compliantly.

Clinical
Evidence
Medical
Necessity
Payer
Consideration
HCP
Consideration

Helping to Achieve the Triple Aim by Improving:

1

Health of Populations

Reduces unnecessary invasive coronary angiograms (ICA)1
2

Experience of Care

  • Helps direct patients to the most appropriate care1
  • Provides a better patient experience2
3

Per Capita Costs of Care

Reduces overall costs to the healthcare system3
For more information, please contact our reimbursement representatives.
Contact Us